HORIZON PHARMA INVT LTD's ticker is and the CUSIP is 44052TAB7. A total of 34 filers reported holding HORIZON PHARMA INVT LTD in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $1,860,000 | +2.4% | 2,000 | 0.0% | 0.14% | +12.5% |
Q3 2017 | $1,816,000 | +5.3% | 2,000 | 0.0% | 0.12% | +5.3% |
Q2 2017 | $1,725,000 | -6.6% | 2,000 | 0.0% | 0.11% | -25.5% |
Q1 2017 | $1,846,000 | -3.1% | 2,000 | 0.0% | 0.15% | -15.0% |
Q4 2016 | $1,906,000 | -51.0% | 2,000 | -48.5% | 0.18% | +1536.4% |
Q3 2016 | $3,886,000 | +112.0% | 3,886 | -99.8% | 0.01% | -95.5% |
Q2 2016 | $1,833,000 | – | 2,000,000 | – | 0.24% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|